NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗傳染病疫苗市場(2021-2031):產品類型、疾病類型(細菌/病毒)、分銷渠道預測、地區/主要國家市場分析、主要公司、COVID-19復甦情景

Anti-infective Vaccines Market Report 2021-2031: Forecasts by Product Type, by Disease Type (Bacterial/Viral), by Distribution Channel, Regional & Leading National Market Analysis, Leading Companies, COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 1022272
出版日期 內容資訊 英文 375 Pages
商品交期: 最快1-2個工作天內
價格
抗傳染病疫苗市場(2021-2031):產品類型、疾病類型(細菌/病毒)、分銷渠道預測、地區/主要國家市場分析、主要公司、COVID-19復甦情景 Anti-infective Vaccines Market Report 2021-2031: Forecasts by Product Type, by Disease Type (Bacterial/Viral), by Distribution Channel, Regional & Leading National Market Analysis, Leading Companies, COVID-19 Recovery Scenarios
出版日期: 2021年06月01日內容資訊: 英文 375 Pages
簡介

抗傳染病疫苗市場受到各國政府之間廣泛合作的推動,旨在通過旨在預防高發病率和高死亡率傳染病傳播的疫苗接種計劃來提高人們對疫苗接種益處的認識。預計該市場將會發展。政府機構和非政府組織在該行業中變得越來越重要,預計將顯著促進垂直增長。

聯合國兒童基金會和世衛組織發佈了在全球範圍內製定國家免疫規劃(稱為綜合多年規劃 (cMYP))的指南。目的是通過確保所有人公平獲得疫苗接種設施以及製定和實施可行的財務戰略,增加利益相關者對實現疫苗接種率目標的參與。

本報告從市場規模和預測、市場份額、成長和抑制因素、機遇和挑戰、產品類型/疾病類型、分銷渠道、地區/國家等方面調查了全球抗傳染病疫苗市場。市場分析、競爭形勢和主要公司簡介。

目錄

第 1 章報告概述

第 2 章執行摘要

第 3 章市場動態

  • 成長因素
    • 提高疫苗接種意識以推動抗感染疫苗市場
    • 傳染病發病率增加
    • 加大研發力度,到2031年推動抗傳染病疫苗市場增長
    • 增加政府對免疫計劃的關注
  • 抑制因素
    • 缺乏熟練的專業人員
    • 整個中低收入國家經濟體缺乏疫苗接種意識
    • COVID-19 中的供應鏈中斷以抑制市場增長
  • 市場機會
    • 擴大政府支持以提供良好的增長前景
    • 提供良好增長前景的新發傳染病
    • 提高疫苗滲透率
  • SWOT 分析
  • 行業分析-波特五力分析
  • 行業分析-PEST分析

第 4 章按疾病類型分列的抗感染疫苗市場

  • 細菌性傳染病:細分市場預測(2021-2031)
    • 推動細分市場增長的細菌性傳染病流行率增加
    • 傷寒疫苗市場預測(2021-2031)
    • 結核病疫苗市場預測(2021-2031)
    • 破傷風和白喉疫苗市場預測(2021-2031)
    • 其他
    • 細菌傳染病細分預測(2021-2031)
    • COVID-19 影響恢復情景
  • 病毒性傳染病:細分市場預測(2021-2031)
    • 病毒性疾病板塊佔據大部分市場份額
    • 流感疫苗市場預測(2021-2031)
    • 肝炎疫苗市場預測(2021-2031)
    • 脊髓灰質炎疫苗市場預測(2021-2031)
    • 病毒病段預測(2021-2031)
    • COVID-19 影響恢復情景

第 5 章按產品類型分列的抗感染疫苗市場

  • 生/弱毒疫苗細分市場預測(2021-2031)
    • 對新的疾病特異性療法的高需求以推動活疫苗/減毒疫苗市場的增長
    • COVID-19 影響恢復情景
  • 滅活疫苗細分市場預測(2021-2031)
    • 對滅活疫苗的需求不斷增加,以促進新興經濟體的細分市場增長
    • COVID-19 影響恢復情景
  • DNA 和重組載體疫苗細分市場預測(2021-2031)
    • 預計到 2031 年,技術進步將推動細分市場的增長
    • COVID-19 影響恢復情景
  • 其他細分市場預測(2021-2031)
    • COVID-19 影響恢復情景

第 6 章按分銷渠道劃分的抗傳染病疫苗市場

  • 醫院/診所細分市場預測(2021-2031)
    • COVID-19 影響恢復情景
  • 公立醫院細分市場預測(2021-2031)
    • COVID-19 影響恢復情景
  • 私人診所細分市場預測(2021-2031)
    • COVID-19 影響恢復情景
  • 零售藥房/藥店細分市場預測(2021-2031)
    • COVID-19 影響恢復情景
  • 電子商務細分市場預測(2021-2031)
    • COVID-19 影響恢復情景

第 7 章區域和主要國家抗傳染病疫苗市場預測(2021-2031)

  • 區域預測(2021-2031)另一個世界抗感染疫苗市場
  • COVID-19 影響恢復情景

第 8 章北美抗傳染病疫苗市場

  • 北美目前主導全球抗傳染病疫苗市場
  • 按國家/地區分列的北美抗感染疫苗市場預測(2021-2031)
  • 按產品類型
  • 按疾病類型
  • 細菌性疾病
  • 按病毒性疾病
  • 按分銷渠道
  • 美國抗傳染病疫苗市場預測(2021-2031)
    • 美國目前主導全球抗感染藥物市場
    • 到 2031 年促進區域性抗感染疫苗增長的負擔得起的衛生實踐
    • COVID-19 影響恢復情景:美國抗傳染病疫苗市場預測(2021-2031)
  • 加拿大抗傳染病疫苗市場預測(2021-2031)
    • 增加政府舉措以促進加拿大抗傳染病疫苗市場的增長
    • 加拿大衛生部在免疫計劃中發揮著至關重要的作用
    • COVID-19 影響恢復情景:加拿大抗傳染病疫苗市場預測(2021-2031)

第 9 章歐洲抗傳染病疫苗市場

  • 不斷增加的創新加上眾多的研究站點,以推動歐洲抗感染藥物市場的增長
  • 歐洲各國抗傳染病疫苗市場預測(2021-2031)
  • 按產品類型
  • 按疾病類型
  • 按細菌性疾病
  • 按病毒性疾病
  • 按分銷渠道
  • 德國抗傳染病疫苗市場預測(2021-2031)
    • 增加流感負擔推動德國抗感染疫苗市場增長
    • 全民醫保體係有望提振德國抗感染疫苗市場增長
    • COVID-19 影響恢復情景:德國抗傳染病疫苗市場預測(2021-2031)
  • 法國抗傳染病疫苗市場預測(2021-2031)
    • 一項促進法國抗感染疫苗發展的基本免疫計劃
    • 對疫苗安全性的不可靠信心遏制市場增長
    • COVID-19 影響恢復情景:法國抗傳染病疫苗市場預測(2021-2031)
  • 英國抗傳染病疫苗市場預測(2021-2031)
    • 季節性傳播負擔對整個英國抗感染疫苗的需求
    • 預計英國仍將是歐盟抗感染疫苗市場的主要參與者
    • COVID-19 影響恢復情景:英國抗傳染病疫苗市場預測(2021-2031)
  • 意大利抗傳染病疫苗市場預測(2021-2031)
    • 增加政府對支持區域增長的免疫計劃的關注
    • 經濟衰退可能會阻礙未來十年抗感染疫苗的發展
    • COVID-19 影響恢復情景:意大利抗傳染病疫苗市場預測(2021-2031)
  • 西班牙抗傳染病疫苗市場預測(2021-2031)
    • 流感病例增加推動西班牙抗感染疫苗市場增長
    • 到 2031 年改善經濟狀況以促進西班牙抗感染疫苗市場的增長
    • COVID-19 影響恢復情景:西班牙抗傳染病疫苗市場預測(2021-2031)
  • 俄羅斯抗傳染病疫苗市場預測(2021-2031)
    • 到 2031 年,季節性流感案例將推動抗傳染病疫苗市場的增長
    • COVID-19 影響恢復情景:俄羅斯抗傳染病疫苗市場預測(2021-2031)
  • 其他歐洲抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:其他歐洲抗傳染病疫苗市場預測(2021-2031)

第 10 章亞太抗感染疫苗市場

  • 2031年亞太抗感染疫苗市場增速最高
  • 按國家分列的亞太抗傳染病疫苗市場,預測(2021-2031)
  • 按產品類型
  • 按疾病類型
  • 細菌性疾病
  • 按病毒性疾病
  • 按分銷渠道
  • 中國抗感染疫苗市場預測(2021-2031)
    • 中國目前主導著亞太抗傳染病疫苗市場
    • 國內疫苗信心不足阻礙抗感染疫苗在中國的發展
    • COVID-19 影響恢復情景:中國抗傳染病疫苗市場預測(2021-2031)
  • 日本抗感染疫苗市場預測(2021-2031)
    • 季節性流感爆發促進日本抗感染疫苗增長
    • 存在較大疫苗缺口推動日本抗感染疫苗市場增長
    • COVID-19 影響恢復情景:日本抗傳染病疫苗市場預測(2021-2031)
  • 印度抗傳染病疫苗市場預測(2021-2031)
    • 印度有望成為亞太地區最高的增長率
    • 整個印度的抗傳染病疫苗製造商潛力巨大
    • COVID-19 影響恢復情景:印度抗傳染病疫苗市場預測(2021-2031)
  • 澳大利亞抗傳染病疫苗市場預測(2021-2031)
    • 增加政府支持以促進澳大利亞抗感染疫苗市場的增長
    • COVID-19 影響恢復情景:澳大利亞抗傳染病疫苗市場預測(2021-2031)
  • 其他亞太抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:其他亞太地區抗傳染病疫苗市場預測(2021-2031)

第 11 章拉丁美洲抗傳染病疫苗市場

  • 巴西有望在 2031 年推動拉丁美洲抗感染疫苗市場的增長
  • 按國家/地區分列的拉丁美洲抗感染疫苗市場,預測(2021-2031)
  • 按產品類型
  • 按疾病類型
  • 細菌性疾病
  • 按病毒性疾病
  • 按分銷渠道
  • 巴西抗傳染病疫苗市場預測(2021-2031)
    • 政府專注於免疫計劃以促進巴西抗感染疫苗市場的增長
    • 繼續發展巴西的國家醫療保健系統以促進區域增長
    • COVID-19 影響恢復情景:巴西抗傳染病疫苗市場預測(2021-2031)
  • 墨西哥抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:墨西哥抗傳染病疫苗市場預測(2021-2031)
  • 其他拉丁美洲抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:其他拉丁美洲抗傳染病疫苗市場預測(2021-2031)

第 12 章中東/非洲抗傳染病疫苗市場

  • 中東和非洲有望在預測期內提供巨大的增長前景
  • 按國家/地區分列的中東/非洲抗傳染病疫苗市場,預測(2021-2031)
  • 按產品類型
  • 按疾病類型
  • 細菌性疾病
  • 按病毒性疾病
  • 按分銷渠道
  • 海灣合作委員會國家抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:海灣合作委員會國家抗傳染病疫苗市場預測(2021-2031)
  • 南非抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:南非抗傳染病疫苗市場預測(2021-2031)
  • 其他中東/非洲其他抗傳染病疫苗市場預測(2021-2031)
    • COVID-19 影響恢復情景:其他中東/非洲抗傳染病疫苗市場預測(2021-2031)

第 13 章公司簡介

  • Evotec
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Merck&Co, Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • GlaxoSmithKline plc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Emergent BioSolutions Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品線
    • 近期趨勢
  • Valneva SE
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • CSL Limited (Seqirus)
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Pfizer
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Serum Institute of India Pvt. Ltd.
    • 公司快照
    • 公司簡介
    • 產品基準
    • 近期趨勢
  • BioDiem
    • 公司快照
    • 公司簡介
    • 產品基準
  • Mitsubishi Tanabe Pharma Corporation
    • 公司快照
    • 公司簡介
    • 產品線
    • 近期趨勢
  • Sinovac Biotech Ltd.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
  • Bavarian Nordic
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Berna Biotech Pharma GmbH
    • 公司快照
    • 公司簡介
    • 產品基準
    • 近期發展
  • Hookipa Pharma Inc.
    • 公司快照
    • 公司簡介
    • 產品基準
  • Syneos Health
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢

第 14 章結論

  • 結論
  • 推薦
目錄
Product Code: PHA1034

Title:
Anti-infective Vaccines Market Report 2021-2031
Forecasts by Product Type (Live/Attenuated Vaccines, Inactivated Vaccines, DNA & Recombinant Vector Vaccines, Others), by Disease Type (Bacterial Diseases (Typhoid Vaccines, Tuberculosis Vaccines, Tetanus & Diphtheria Vaccines, Others), Viral Diseases (Influenza Vaccines, Hepatitis Vaccines, Polio Vaccines, Others)), by Distribution Channel (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Anti-infective Vaccines Companies AND COVID-19 Recovery Scenarios.

Growing Government Focus on Immunization Programs

The anti-infective vaccines market is predicted to develop due to a broad coalition of governments striving to raise awareness of the benefits of vaccination through immunisation programs with the goal of preventing the spread of communicable illnesses that are linked with high morbidity and mortality. For example, the 'Immunize Australia Program' funds individual immunisation, which serves as a preventative measure in reducing illness onset and limiting illness transmission, therefore sparing millions of Australians from serious diseases. The growing significance of government and non-government organisations in this industry is likely to give the vertical a significant boost. UNICEF and the WHO have released guidelines for developing a national immunisation plan, known as the Comprehensive Multi-Year Plan (cMYP), for all countries around the world, with the goal of ensuring equitable access to vaccination facilities for all people and increasing stakeholder participation in meeting vaccination coverage targets by designing and implementing feasible financial strategies.

Which Factors are Driving the Global Anti-Infective Vaccines Market?

  • Growing Vaccination Awareness to Boost Anti-Infective Vaccines Market
  • Increasing Incidence of Infectious Diseases
  • Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
  • Growing Government Focus on Immunization Programs

What are the Market Opportunities for Global Anti-Infective Vaccines Market?

  • Growing Government Support to Offer Lucrative Growth Prospects
  • Emerging Infectious Diseases to Offer Lucrative Growth Prospects
  • Increasing Vaccine Penetration Coverage

Discover how to stay ahead

Our 370+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Infective Vaccines Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter's Five Forces, SWOT Analysis, product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and sub-markets

Product Type

  • Live/Attenuated Vaccines
  • Inactivated Vaccines
  • DNA & Recombinant Vector Vaccines
  • Others

Disease Type

  • Bacterial Diseases
    • Typhoid Vaccines
    • Tuberculosis Vaccines
    • Tetanus & Diphtheria Vaccines
    • Others
  • Viral Diseases
    • Influenza Vaccines
    • Hepatitis Vaccines
    • Polio Vaccines
    • Others

Distribution Channel

  • Hospitals Clinics
  • Public Hospitals
  • Private Clinics
  • Retail Pharmacies and Drug Stores
  • E-commerce

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Anti-Infective Vaccines Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Anti-Infective Vaccines Market report helps you

In summary, our 370+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Anti-Infective Vaccines Market, with forecasts for Product Type, Disease Type, and Distribution Channel, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 16 key national markets- See forecasts for the Anti-Infective Vaccines market in North America, Europe, Asia Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Mexico, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 15 of the companies involved in the Anti-Infective Vaccines Market. Some of the company's profiled in this report include Evotec, Merck & Co, Inc., GlaxoSmithKline plc., Emergent BioSolutions Inc., Valneva SE, CSL Limited, Pfizer, Serum Institute of India Pvt. Ltd., BioDiem, Mitsubishi Tanabe Pharma Corporation, Sinovac Biotech Ltd., Bavarian Nordic, Berna Biotech Pharma GmbH, Hookipa Pharma Inc., and Syneos Health among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Anti-Infective Vaccines Market and leading companies. You will find data, trends, and predictions.

Buy our report today“ Anti-infective Vaccines Market Report 2021-2031: Forecasts by Product Type (Live/Attenuated Vaccines, Inactivated Vaccines, DNA & Recombinant Vector Vaccines, Others), by Disease Type (Bacterial Diseases (Typhoid Vaccines, Tuberculosis Vaccines, Tetanus & Diphtheria Vaccines, Others), Viral Diseases (Influenza Vaccines, Hepatitis Vaccines, Polio Vaccines, Others)), by Distribution Channel (Hospitals, Clinics, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Anti-infective Vaccines Companies AND COVID-19 Recovery Scenarios. ” Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Anti-Infective Vaccines Market
  • 1.2 Anti-Infective Vaccines Market Definition
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 COVID-19 Impact: Recovery Scenarios
    • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Dynamics

  • 3.1 Drivers
    • 3.1.1 Growing Vaccination Awareness to Boost Anti-Infective Vaccines Market
    • 3.1.2 Increasing Incidence of Infectious Diseases
    • 3.1.3 Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
    • 3.1.4 Growing Government Focus on Immunization Programs
  • 3.2 Restraints
    • 3.2.1 Lack of Skilled Professionals
    • 3.2.2 Lack of Vaccination Awareness Across LMIC Economies
    • 3.2.3 Supply Chain Disruption Amid COVID-19 to Restrain Market Growth
  • 3.3 Opportunities
    • 3.3.1 Growing Government Support to Offer Lucrative Growth Prospects
    • 3.3.2 Emerging Infectious Diseases to Offer Lucrative Growth Prospects
    • 3.3.3 Increasing Vaccine Penetration Coverage
  • 3.4 SWOT Analysis
    • 3.4.1 Strengths
    • 3.4.2 Weaknesses
    • 3.4.3 Opportunities
    • 3.4.4 Threats
  • 3.5 Industry analysis - Porter's
    • 3.5.1 Buyer Power
    • 3.5.2 Supplier Power
    • 3.5.3 Competitive Rivalry
    • 3.5.4 Threat of Substitute
    • 3.5.5 Threat of New Entrants
  • 3.6 Industry analysis - PEST Analysis
    • 3.6.1 Political Factors Impacting Anti-Infective Vaccines Market
    • 3.6.2 Economic Factors Impacting Anti-Infective Vaccines Market
    • 3.6.3 Social Factors Impacting Anti-Infective Vaccines Market
    • 3.6.4 Technological Factors Impacting Anti-Infective Vaccines Market

4 Anti-Infective Vaccines Market by Disease Type

  • 4.1 Bacterial Diseases Segment Market Forecast, 2021-2031
    • 4.1.1 Rising Prevalence of Bacterial Infection Diseases to Fuel Segmental Market Growth
    • 4.1.2 Typhoid Vaccines Market Forecast, 2021-2031
    • 4.1.3 TB Vaccines Market Forecast, 2021-2031
    • 4.1.4 Tetanus and Diphtheria Vaccines Market Forecast, 2021-2031
    • 4.1.5 Others
    • 4.1.6 Bacterial Diseases Segment Forecast, 2021-2031
    • 4.1.7 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.2 Viral Diseases Segment Market Forecast, 2021-2031
    • 4.2.1 Viral Diseases Segment Accounts for Majority of the Market Share
    • 4.2.2 Influenza Vaccines Market Forecast, 2021-2031
    • 4.2.3 Hepatitis Vaccines Market Forecast, 2021-2031
    • 4.2.4 Polio Vaccines Market Forecast, 2021-2031
    • 4.2.5 Viral Diseases Segment Forecast, 2021- 2031
    • 4.2.6 COVID-19 Impact Recovery Scenarios (V, U, W, L)

5 Anti-Infective Vaccines Market by Product Type

  • 5.1 Live/Attenuated Vaccines Segment Market Forecast, 2021-2031
    • 5.1.1 High Demand of Disease Specific Novel Therapies to Fuel Live/Attenuated Vaccines Market Growth
    • 5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.2 Inactivated Vaccines Segment Market Forecast, 2021-2031
    • 5.2.1 Rising Demand for Inactivated Vaccines from Emerging Economies to Fuel Segmental Growth
    • 5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.3 DNA & Recombinant Vector Vaccines Segment Market Forecast, 2021-2031
    • 5.3.1 Technological Advancements Anticipated to Fuel Segmental Growth Through 2031
    • 5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.4 Others Segment Market Forecast, 2021-2031
    • 5.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

6 Anti-Infective Vaccines Market by Distribution Channel

  • 6.1 Hospital Clinics Segment Market Forecast, 2021-2031
    • 6.1.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.2 Public Hospitals Segment Market Forecast, 2021-2031
    • 6.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.3 Private Clinics Segment Market Forecast, 2021-2031
    • 6.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.4 Retail Pharmacies & Drug Stores Segment Market Forecast, 2021-2031
    • 6.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.5 E-Commerce Segment Market Forecast, 2021-2031
    • 6.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 Regional and Leading National Anti-Infective Vaccines Market Forecasts 2021-2031

  • 7.1 Global Anti-Infective Vaccines Market by Region Forecast 2021-2031
  • 7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

8 North America Anti-Infective Vaccines Market

  • 8.1 North America Currently Dominates the Worldwide Anti-Infective Vaccines Market
  • 8.2 North America Anti-Infective Vaccines Market by Country, Forecast 2021-2031
  • 8.3 North America Anti-Infective Vaccines Market Forecast by Product Type
  • 8.4 North America Anti-Infective Vaccines Market Forecast by Disease Type
  • 8.5 North America Anti-Infective Vaccines Market Forecast by Bacterial Diseases
  • 8.6 North America Anti-Infective Vaccines Market Forecast by Viral Diseases
  • 8.7 North America Anti-Infective Vaccines Market Forecast by Distribution Channel
  • 8.8 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031
    • 8.8.1 U.S. Currently Dominates the Worldwide Anti-Infectives Market
    • 8.8.2 Affordable Health Act to Fuel Regional Growth of Anti-Infective Vaccines Through 2031
    • 8.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Anti-Infective Vaccines Market Forecast, 2021-2031
  • 8.9 Canada Anti-Infective Vaccines Market Forecast, 2021-2031
    • 8.9.1 Rising Government Initiatives to Boost Canadian Anti-Infective Vaccines Market Growth
    • 8.9.2 Health Canada Plays a Pivotal Role in Immunization Programmes
    • 8.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Anti-Infective Vaccines Market Forecast, 2021-2031

9 Europe Anti-Infective Vaccines Market

  • 9.1 Rising Innovation Coupled with Numerous Research Sites to Fuel European Anti-Infectives Market Growth
  • 9.2 Europe Anti-Infective Vaccines Market by Country, Forecast 2021-2031
  • 9.3 Europe Anti-Infective Vaccines Market Forecast by Product Type
  • 9.4 Europe Anti-Infective Vaccines Market Forecast by Disease Type
  • 9.5 Europe Anti-Infective Vaccines Market Forecast by Bacterial Diseases
  • 9.6 Europe Anti-Infective Vaccines Market Forecast by Viral Diseases
  • 9.7 Europe Anti-Infective Vaccines Market Forecast by Distribution Channel
  • 9.8 Germany Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.8.1 Rising Influenza Burden to Fuel German Anti-Infective Vaccines Market Growth
    • 9.8.2 Universal Healthcare System Anticipated to Boost German Anti-Infective Vaccines Market Growth
    • 9.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Anti-Infective Vaccines Market Forecast, 2021-2031
  • 9.9 France Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.9.1 Mandatory Immunization Programmes to Fuel French Anti-Infective Vaccines Growth
    • 9.9.2 Low Confidence in Vaccines Safety to Restrain Market Growth
    • 9.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Anti-Infective Vaccines Market Forecast, 2021-2031
  • 9.10 UK Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.10.1 Seasonal Infection Burden to Demand for Anti-infective Vaccines Across UK Region
    • 9.10.2 UK Anticipated to Remain a Key Player in EU Anti-Infective Vaccines Market
    • 9.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Anti-Infective Vaccines Market Forecast, 2021-2031
  • 9.11 Italy Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.11.1 Rising Government Focus on Immunization Programmes to Boost Regional Growth
    • 9.11.2 Economic Downturn Likely to Hamper Anti-Infective Vaccines Growth Over the Next Decade
    • 9.11.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Anti-Infective Vaccines Market Forecast, 2021-2031
  • 9.12 Spain Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.12.1 Rising Flu Cases to Fuel Spanish Anti-Infective Vaccines Market Growth
    • 9.12.2 Improving Economic Conditions to Boost Spanish Anti-Infective Vaccines Market Growth Through 2031
    • 9.12.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Anti-Infective Vaccines Market Forecast, 2021-2031
  • 9.13 Russia Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.13.1 Seasonal Flu Instances to Augur Anti-Infective Vaccines Market Growth Through 2031
    • 9.13.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Anti-Infective Vaccines Market Forecast, 2021-2031
  • 9.14 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031
    • 9.14.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031

10 Asia Pacific Anti-Infective Vaccines Market

  • 10.1 Asia Pacific Anti-Infective Vaccines Market to Witness Highest Growth Rate Through 2031
  • 10.2 Asia Pacific Anti-Infective Vaccines Market by Country, Forecast 2021-2031
  • 10.3 Asia Pacific Anti-Infective Vaccines Market Forecast by Product Type
  • 10.4 Asia Pacific Anti-Infective Vaccines Market Forecast by Disease Type
  • 10.5 Asia Pacific Anti-Infective Vaccines Market Forecast by Bacterial Diseases
  • 10.6 Asia Pacific Anti-Infective Vaccines Market Forecast by Viral Diseases
  • 10.7 Asia Pacific Anti-Infective Vaccines Market Forecast by Distribution Channel
  • 10.8 China Anti-Infective Vaccines Market Forecast, 2021-2031
    • 10.8.1 China Currently Dominates the APAC Anti-Infective Vaccines Market
    • 10.8.2 Low Confidence Towards Domestic Vaccines to Hamper Chinese Anti-Infective Vaccines Growth
    • 10.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Anti-Infective Vaccines Market Forecast, 2021-2031
  • 10.9 Japan Anti-Infective Vaccines Market Forecast, 2021-2031
    • 10.9.1 Seasonal Flu Outbreaks to Fuel Japanese Anti-Infective Vaccines Growth
    • 10.9.2 Presence of Large Vaccine Gap to Fuel Japanese Anti-Infective Vaccines Market Growth
    • 10.9.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Anti-Infective Vaccines Market Forecast, 2021-2031
  • 10.10 India Anti-Infective Vaccines Market Forecast, 2021-2031
    • 10.10.1 India Anticipated to Witness Highest Growth Across APAC Region
    • 10.10.2 Great Potential for Anti-Infective Vaccine Manufacturers Across the Indian Region
    • 10.10.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Anti-Infective Vaccines Market Forecast, 2021-2031
  • 10.11 Australia Anti-Infective Vaccines Market Forecast, 2021-2031
    • 10.11.1 Rising Government Support to Fuel Australian Anti-Infective Vaccines Market Growth
    • 10.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Anti-Infective Vaccines Market Forecast, 2021-2031
  • 10.12 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031
    • 10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031

11 Latin America Anti-Infective Vaccines Market

  • 11.1 Brazil Anticipated to Fuel LATAM Anti-Infective Vaccines Market Growth Through 2031
  • 11.2 Latin America Anti-Infective Vaccines Market by Country, Forecast 2021-2031
  • 11.3 Latin America Anti-Infective Vaccines Market Forecast by Product Type
  • 11.4 Latin America Anti-Infective Vaccines Market Forecast by Disease Type
  • 11.5 Latin America Anti-Infective Vaccines Market Forecast by Bacterial Diseases
  • 11.6 Latin America Anti-Infective Vaccines Market Forecast by Viral Diseases
  • 11.7 Latin America Anti-Infective Vaccines Market Forecast by Distribution Channel
  • 11.8 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031
    • 11.8.1 Government Focus on Immunization Programmes to Boost Brazilian Anti-Infective Vaccines Market Growth
    • 11.8.2 Continuous Development of Brazilian Universal Healthcare System to Fuel Regional Growth
    • 11.8.3 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Anti-Infective Vaccines Market Forecast, 2021-2031
  • 11.9 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031
    • 11.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Anti-Infective Vaccines Market Forecast, 2021-2031
  • 11.10 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031
    • 11.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031

12 Middle East and Africa Anti-Infective Vaccines Market

  • 12.1 MEA Anticipated to Offer Immense Growth Prospects Over the Forecast Period
  • 12.2 Middle East and Africa Anti-Infective Vaccines Market by Country, Forecast 2021-2031
  • 12.3 Middle East and Africa Anti-Infective Vaccines Market Forecast by Product Type
  • 12.4 Middle East and Africa Anti-Infective Vaccines Market Forecast by Disease Type
  • 12.5 MEA Anti-Infective Vaccines Market Forecast by Bacterial Diseases
  • 12.6 MEA Anti-Infective Vaccines Market Forecast by Viral Diseases
  • 12.7 Middle East and Africa Anti-Infective Vaccines Market Forecast by Distribution Channel
  • 12.8 GCC Anti-Infective Vaccines Market Forecast, 2021-2031
    • 12.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Anti-Infective Vaccines Market Forecast, 2021-2031
  • 12.9 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031
    • 12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Anti-Infective Vaccines Market Forecast, 2021-2031
  • 12.10 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031
    • 12.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031

13 Company Profiles

  • 13.1 Evotec
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis, 2015-2020
    • 13.1.4 Product Benchmarking
    • 13.1.5 Recent Developments
  • 13.2 Merck & Co, Inc.
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis, 2015-2020
    • 13.2.4 Product Benchmarking
    • 13.2.5 Recent Developments
  • 13.3 GlaxoSmithKline plc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis, 2015-2020
    • 13.3.4 Product Benchmarking
    • 13.3.5 Recent Developments
  • 13.4 Emergent BioSolutions Inc.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis, 2015-2020
    • 13.4.4 Product Pipeline
    • 13.4.5 Recent Developments
  • 13.5 Valneva SE
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis, 2015-2020
    • 13.5.4 Product Benchmarking
    • 13.5.5 Recent Developments
  • 13.6 CSL Limited (Seqirus)
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis, 2015-2020
    • 13.6.4 Product Benchmarking
    • 13.6.5 Recent Developments
  • 13.7 Pfizer
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis, 2015-2020
    • 13.7.4 Product Benchmarking
    • 13.7.5 Recent Developments
  • 13.8 Serum Institute of India Pvt. Ltd.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Product Benchmarking
    • 13.8.4 Recent Developments
  • 13.9 BioDiem
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Product Benchmarking
  • 13.10 Mitsubishi Tanabe Pharma Corporation
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Product Pipeline
    • 13.10.4 Recent Developments
  • 13.11 Sinovac Biotech Ltd.
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis, 2015-2020
    • 13.11.4 Product Benchmarking
  • 13.12 Bavarian Nordic
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis, 2015-2020
    • 13.12.4 Product Benchmarking
    • 13.12.5 Recent Developments
  • 13.13 Berna Biotech Pharma GmbH
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Product Benchmarking
    • 13.13.4 Recent Developments
  • 13.14 Hookipa Pharma Inc.
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Product Benchmarking
  • 13.15 Syneos Health
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Financial Analysis, 2015-2020
    • 13.15.4 Product Benchmarking
    • 13.15.5 Recent Developments

14 Conclusion

  • 14.1 Concluding Remarks
  • 14.2 Recommendations

List of Tables

  • Table 1 Global Anti-Infective Vaccines Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
  • Table 2 Global Tuberculosis Incidences (Total of new and relapse cases and cases with unknown previous TB treatment history)
  • Table 3 Global Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 4 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 5 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 6 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 7 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 8 Global Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 9 Reported Cases of Polio (as of 2019) -
  • Table 10 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 11 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 12 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 13 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 14 Global Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 15 Global Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 16 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 17 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 18 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 19 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 20 Anti-Infective Vaccines Market Forecast for Live/Attenuated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 21 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 22 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 23 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 24 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 25 Anti-Infective Vaccines Market Forecast for Inactivated Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 26 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 27 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 28 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 29 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 30 Anti-Infective Vaccines Market Forecast for DNA & Recombinant Vector Vaccines, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 31 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 32 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 33 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 34 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 35 Anti-Infective Vaccines Market Forecast for Others, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 36 Global Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 37 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 38 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 39 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 40 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 41 Anti-Infective Vaccines Market Forecast for Hospitals Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 42 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 43 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 44 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 45 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 46 Anti-Infective Vaccines Market Forecast for Public Hospitals, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 47 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 48 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 49 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 50 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 51 Anti-Infective Vaccines Market Forecast for Private Clinics, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 52 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 53 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 54 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 55 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 56 Anti-Infective Vaccines Market Forecast for Retail Pharmacies and Drug Stores, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 57 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 58 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 59 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 60 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 61 Anti-Infective Vaccines Market Forecast for E-commerce, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 62 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 63 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 64 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 65 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 66 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 67 North America Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 68 North America Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 69 North America Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 70 North America Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 71 North America Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 72 North America Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 73 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 74 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 75 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 76 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 77 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 78 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 79 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 80 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 81 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 82 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 83 Europe Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 84 Europe Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 85 Europe Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 86 Europe Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 87 Europe Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 88 Europe Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 89 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 90 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 91 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 92 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 93 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 94 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 95 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 96 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 97 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 98 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 99 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 100 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 101 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 102 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 103 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 104 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 105 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 106 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 107 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 108 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 109 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 110 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 111 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 112 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 113 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 114 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 115 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 116 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 117 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 118 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 119 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 120 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 121 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 122 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 123 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 124 Healthcare Spending Data for Asian Countries:
  • Table 125 incidences of various infective diseases across Asia-Pacific
  • Table 126 APAC Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 127 APAC Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 128 APAC Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 129 APAC Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 130 APAC Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 131 APAC Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 132 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 133 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 134 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 135 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 136 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 137 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 138 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 139 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 140 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 141 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 142 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 143 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 144 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 145 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 146 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 147 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 148 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 149 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 150 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 151 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 152 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 153 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 154 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 155 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 156 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 157 Incidences of various infective diseases across Latin America
  • Table 158 Latin America Healthcare Spending potential
  • Table 159 LATAM Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 160 LATAM Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 161 LATAM Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 162 LATAM Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 163 LATAM Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 164 LATAM Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 165 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 166 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 167 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 168 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 169 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 170 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 171 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 172 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 173 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 174 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 175 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 176 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 177 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 178 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 179 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 180 disease incidences in the African region
  • Table 181 MEA Anti-Infective Vaccines Market Forecast by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 182 MEA Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 183 MEA Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 184 MEA Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 185 MEA Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 186 MEA Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 187 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 188 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 189 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 190 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 191 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 192 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 193 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 194 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 195 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 196 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 197 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 198 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 199 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 200 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 201 Rest of MEA Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 202 Evotec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 203 Evotec: Product Benchmarking
  • Table 204 Evotec: Recent Developments
  • Table 205 Merck & Co, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 206 Merck & Co, Inc.: Product Benchmarking
  • Table 207 Merck & Co, Inc.: Recent Developments
  • Table 208 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 209 GlaxoSmithKline plc.: Product Benchmarking
  • Table 210 GlaxoSmithKline plc.: Recent Developments
  • Table 211 Emergent BioSolutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 212 Emergent BioSolutions Inc.: Product Pipeline
  • Table 213 Emergent BioSolutions Inc.: Recent Developments
  • Table 214 Valneva SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 215 Valneva SE: Product Benchmarking
  • Table 216 Valneva SE: Recent Developments
  • Table 217 CSL Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 218 CSL Limited: Product Benchmarking
  • Table 219 CSL Limited: Recent Developments
  • Table 220 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 221 Pfizer: Product Benchmarking
  • Table 222 Pfizer: Recent Developments
  • Table 223 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 224 Serum Institute of India Pvt. Ltd.: Product Benchmarking
  • Table 225 Serum Institute of India Pvt. Ltd.: Recent Developments
  • Table 226 BioDiem: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 227 BioDiem: Product Benchmarking
  • Table 228 Mitsubishi Tanabe Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 229 Mitsubishi Tanabe Pharma Corporation: Product Pipeline
  • Table 230 Mitsubishi Tanabe Pharma Corporation: Recent Developments
  • Table 231 Sinovac Biotech Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 232 Sinovac Biotech Ltd.: Product Benchmarking
  • Table 233 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 234 Bavarian Nordic: Product Benchmarking
  • Table 235 Bavarian Nordic: Recent Developments
  • Table 236 Berna Biotech Pharma GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 237 Berna Biotech Pharma GmbH: Product Benchmarking
  • Table 238 Berna Biotech Pharma GmbH: Recent Developments
  • Table 239 Hookipa Pharma Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 240 Hookipa Pharma Inc.: Product Benchmarking
  • Table 241 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 242 Syneos Health: Product Benchmarking
  • Table 243 Syneos Health: Recent Developments

List of Figures

  • Figure 1 Global Anti-Infective Vaccines Market: Market Segmentation
  • Figure 2 Global Anti-Infective Vaccines Market: Market Dynamics
  • Figure 3 Global Anti-Infective Vaccines Market: Market Trends
  • Figure 4 Global Anti-Infective Vaccines Market: SWOT Analysis
  • Figure 5 Porter's Analysis
  • Figure 6 Global Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR %)
  • Figure 7 Global Anti-Infective Vaccines Market Share Forecast by Disease Type, 2021, 2026, 2031 (%)
  • Figure 8 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 9 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 10 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 11 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 12 Global Anti-Infective Vaccines Market for Bacterial Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 13 Global Anti-Infective Vaccines Market for Viral Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 14 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 15 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 16 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 17 Global Anti-Infective Vaccines Market for Viral Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 18 Global Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR %)
  • Figure 19 Global Anti-Infective Vaccines Market Share Forecast by Product Type, 2021, 2026, 2031 (%)
  • Figure 20 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 21 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 22 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 23 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 24 Global Anti-Infective Vaccines Market for Live/Attenuated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 25 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 26 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 27 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 28 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 29 Global Anti-Infective Vaccines Market for Inactivated Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 30 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 31 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 32 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 33 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 34 Global Anti-Infective Vaccines Market for DNA & Recombinant Vector Vaccines Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 35 Global Anti-Infective Vaccines Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 36 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 37 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 38 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 39 Global Anti-Infective Vaccines Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 40 Global Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR %)
  • Figure 41 Global Anti-Infective Vaccines Market Share Forecast by Distribution Channel, 2021, 2026, 2031 (%)
  • Figure 42 Global Anti-Infective Vaccines Market for Hospital Clinics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 43 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 44 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 45 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 46 Global Anti-Infective Vaccines Market for Hospital Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 47 Global Anti-Infective Vaccines Market for Public Hospitals Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 48 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 49 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 50 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 51 Global Anti-Infective Vaccines Market for Public Hospitals Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 52 Global Anti-Infective Vaccines Market for Private Clinics Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 53 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 54 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 55 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 56 Global Anti-Infective Vaccines Market for Private Clinics Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 57 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 58 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 59 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 60 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 61 Global Anti-Infective Vaccines Market for Retail Pharmacies & Drug Stores Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 62 Global Anti-Infective Vaccines Market for E-Commerce Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 63 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 64 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 65 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 66 Global Anti-Infective Vaccines Market for E-Commerce Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 67 Global Anti-Infective Vaccines Market Forecast by Region 2021-2031 (US$ million)
  • Figure 68 Global Anti-Infective Vaccines Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 69 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 70 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 71 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 72 Global Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 73 North America Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
  • Figure 74 North America Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 75 North America Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
  • Figure 76 North America Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
  • Figure 77 North America Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 78 North America Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 79 North America Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 80 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 81 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 82 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 83 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 84 U.S. Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 85 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 86 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 87 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 88 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 89 Canada Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 90 Europe Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
  • Figure 91 Europe Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 92 Europe Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
  • Figure 93 Europe Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
  • Figure 94 Europe Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 95 Europe Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 96 Europe Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 97 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 98 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 99 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 100 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 101 Germany Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 102 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 103 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 104 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 105 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 106 France Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 107 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 108 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 109 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 110 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 111 UK Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 112 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 113 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 114 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 115 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 116 Italy Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 117 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 118 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 119 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 120 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 121 Spain Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 122 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 123 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 124 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 125 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 126 Russia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 127 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 128 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 129 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 130 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 131 Rest of Europe Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 132 Asia Pacific Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
  • Figure 133 Asia Pacific Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 134 Asia Pacific Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
  • Figure 135 Asia Pacific Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
  • Figure 136 Asia Pacific Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 137 Asia Pacific Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 138 Asia Pacific Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 139 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 140 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 141 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 142 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 143 China Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 144 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 145 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 146 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 147 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 148 Japan Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 149 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 150 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 151 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 152 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 153 India Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 154 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 155 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 156 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 157 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 158 Australia Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 159 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 160 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 161 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 162 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 163 Rest of Asia Pacific Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 164 Latin America Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
  • Figure 165 Latin America Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 166 Latin America Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
  • Figure 167 Latin America Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
  • Figure 168 Latin America Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 169 Latin America Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 170 Latin America Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 171 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 172 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 173 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 174 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 175 Brazil Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 176 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 177 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 178 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 179 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 180 Mexico Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 181 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 182 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 183 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 184 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 185 Rest of Latin America Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 186 Middle East and Africa Anti-Infective Vaccines Market Forecast by Country 2021-2031 (US$ million)
  • Figure 187 Middle East and Africa Anti-Infective Vaccines Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 188 Middle East and Africa Anti-Infective Vaccines Market Forecast by Product Type, 2021-2031 (US$ million, AGR%)
  • Figure 189 Middle East and Africa Anti-Infective Vaccines Market Forecast by Disease Type, 2021-2031 (US$ million, AGR%)
  • Figure 190 MEA Anti-Infective Vaccines Market Forecast by Bacterial Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 191 MEA Anti-Infective Vaccines Market Forecast by Viral Diseases, 2021-2031 (US$ million, AGR%)
  • Figure 192 Middle East and Africa Anti-Infective Vaccines Market Forecast by Distribution Channel, 2021-2031 (US$ million, AGR%)
  • Figure 193 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 194 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 195 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 196 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 197 GCC Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 198 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 199 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 200 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 201 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 202 South Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 203 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 204 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 205 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 206 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 207 Rest of Middle East and Africa Anti-Infective Vaccines Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 208 Evotec: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 209 Evotec: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 210 Evotec: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 211 Merck & Co, Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 212 Merck & Co, Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 213 Merck & Co, Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 214 GlaxoSmithKline plc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 215 GlaxoSmithKline plc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 216 GlaxoSmithKline plc.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 217 Emergent BioSolutions Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 218 Emergent BioSolutions Inc.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 219 Emergent BioSolutions Inc.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 220 Valneva SE: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 221 Valneva SE: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 222 CSL Limited: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 223 CSL Limited: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 224 CSL Limited: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 225 Pfizer: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 226 Pfizer: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 227 Pfizer: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 228 Sinovac Biotech Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 229 Sinovac Biotech Ltd.: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 230 Sinovac Biotech Ltd.: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 231 Bavarian Nordic: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 232 Bavarian Nordic: R&D Expenses, 2015-2020 (US$ million, AGR%)
  • Figure 233 Bavarian Nordic: Gross Profit, 2015-2020 (US$ million, AGR%)
  • Figure 234 Syneos Health: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 235 Syneos Health: Gross Profit, 2015-2020 (US$ million, AGR%)

Companies Profiled in the Report:

  • Bavarian Nordic
  • Berna Biotech Pharma GmbH
  • BioDiem
  • CSL Limited (Seqirus)
  • Emergent BioSolutions Inc.
  • Evotec
  • GlaxoSmithKline plc.
  • Hookipa Pharma Inc.
  • Merck & Co, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Syneos Health
  • Valneva SE

List of Other Companies:

  • Astellas Pharmaceuticals
  • Bharat Immunologicals and Biologicals Corporation Limited
  • Binnopharm
  • Bio Farma
  • bioCSL
  • BiondVax
  • Bionor
  • Biremx
  • Dynavax
  • Krka Pharmaceuticals
  • MSD Pharmaceuticals
  • Serum Institute of India (SLL)
  • Shionogi Pharmaceuticals
  • Sinopharm
  • SmithKline Beecham
  • Vacsera
  • VaxInnate
  • VaxInnate Corporation

List of Organizations:

  • Advisory Committee for Immunization Practices
  • Brazilian Ministry of Health
  • Butantan Institute
  • Cabtacuzino Institute
  • Center for Biologics Evaluation and Research
  • Centers for Disease Control and Prevention (CDC)
  • Centre for Disease Control and Prevention
  • Chemo-Sero-Therapeutic Research Institute
  • China National Biotech Group
  • China's National Regulatory Authority
  • Chinese Food and Drug Administration
  • ClearPath
  • CureVac
  • Medicago
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • MedImmune
  • Protein Science Corporation
  • Razi Institute
  • The Ministry of Health, Labour and Welfare, Japan
  • The Scripps Research Institute
  • Torlak Institut
  • Ultriks
  • US Department of Health and Human Services
  • WHO Strategic Advisory Group of Experts
  • World Health Organization